Foundation Medicine Q2 FY17: revenue $35.0M, up 24%

Key figures from this report

These are the numbers Foundation Medicine reported for Q2 FY17, the quarter ended Jun 30, 2017, as tagged in the filing’s XBRL data, each against the same quarter a year earlier. A plain-English reading of this report is not written yet.

1. Revenue$35.0M+24% from $28.2M in Q2 FY1610-Q income statement, on EDGAR
2. Net income−$44.3MAgainst −$29.0M in Q2 FY1610-Q income statement, on EDGAR
3. Cash and cash equivalents$36.5M−41% from $62.3M in Q2 FY16Cash and equivalents only; the company page adds short-term investments.10-Q balance sheet, on EDGAR